Pharming Group (NasdaqGM:PHAR) 2026 Investor Day Transcript

Pharming Group (NasdaqGM:PHAR) 2026 Investor Day February 03, 2026 10:00 AM ET Company ParticipantsAmel Karaa - Director of Mitochondrial Disease ProgramAngela Qian - VPAnurag Relan - Chief Medical OfficerFabrice Chouraqui - CEO and Executive DirectorJocelyn Farmer - Director of Clinical Immunodeficiency ProgramJoe Pantginis - Managing Director of Equity ResearchKenneth Lynard - CFOMagnus Hansson - Executive Medical Director and Global Program LeadMichael Levitan - VP Investor Relations and Corporate Commun ...